Precipitated withdrawal in the substantia nigra in diazepam-dependent female rats

Pharmacology Biochemistry and Behavior

Volumn 64, Issue 4, 1999, Pages 857-868

  Wala, Elzbieta P ^a   Sloan, Jewell W ^a   Jing, Xin ^a   Holtman Jr , Joseph R ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Central benzodiazepine receptors; EEG; Flumazenil; Gender; Intranigral injection; Peripheral benzodiazepine receptors; PK 11195

Indexed keywords

BENZODIAZEPINE RECEPTOR; DIAZEPAM; FLUMAZENIL; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; DRUG DEPENDENCE; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; SUBSTANTIA NIGRA;

ANIMALS; ANTI-ANXIETY AGENTS; BODY WEIGHT; DIAZEPAM; ELECTROENCEPHALOGRAPHY; FEMALE; FLUMAZENIL; GABA MODULATORS; ISOQUINOLINES; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; SUBSTANTIA NIGRA;

ANIMALIA;

EID: 0032754547     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00163-X     Document Type: Article

References (100)

1. Baldwin L., File S.E. Flumazenil prevents the development of chlordiapoxide withdrawal in rats tested in the social interaction test of anxiety. Psychopharmacology (Berlin). 97:1986;424-426.
2. Baldwin H.A., Hitchcott P.K., File S.E. The use of flumazenil in prevention of diazepam dependence in the rat. Hum. Psychopharmacol. 5:1990;57-61.
3. Benavides J., Guilloux F., Rufat P., Uzan A., Renault C., Dubroeucq M.-C., Gueremy C., Le Fur G. In vivo labeling in several tissues of "peripheral type" benzodiazepine binding sites. Eur. J. Pharmacol. 99:1984;1-7.
4. 3H] PK 11195, an isoquinoline carboxamide derivative. Kinetic studies and autoradiographic localization J. Neurochem. 41:1983;1744-1750.
5. Bitran D., Carlson D., Leshiner S., Gavish M. Ovarian steroids and stress produce changes in peripheral benzodiazepine receptor density. Eur. J Pharmacol. 361:1998;235-242.
6. Bitran D., Dowd J.A. Ovarian steroids modify the behavioral and neurochemical responses of the central benzodiazepine receptors. Psychopharmacology. 125:1996;65-73.
7. Byrnes J.J., Miller L.G., Perkins K., Greenblatt D.J., Shader R.I. Chronic benzodiazepine administration XI. Concurrent administration of PK. 11195(attenuates lorazepam discontinuation effects. Neuropsychopharmacology 8):1993;267-273.
8. Criswell H.E., Simon P.E., Knapp D.J., Devaud L.L., McCown T.J., Duncan G.E., Morrow A.L., Breese G.R. Effect of zolpidem on γ-aminobutyric acid (GABA)-induced inhibition predicts the interaction of ethanol with GABA on individual neurons in several brain regions. J. Pharmacol. Exp. Ther. 273:1995;526-536.
9. Cymerman U., Pazos A., Palacios J.M. Evidence for species differences in "peripheral" benzodiazepine receptors. An autoradiographic study Neurosci. Lett. 66:1986;153-158.
10. Diaz-Garcia J.M., Oliver-Botana J., Fos-Galve D. Pharmacokinetics of diazepam in the rat. Influence of a carbon tetrachloride-induced hepatic injury J. Pharmacol. Sci. 81:1992;788-792.
11. Fallon J.H., Loughlin S.E. Substantia nigra. Paxinos G. The rat nervous system. 1995;215-237 Academic Press, San Diego.
12. File S.E., Pellow S. The effects of PK1195, a ligand for benzodiazepine binding sites, in animal tests of anxiety and stress. Pharmacol. Biochem. Behav. 23:1985;737-741.
13. Gallager D.W., Henninger K., Henninger G. Periodic benzodiazepine administration prevents benzodiazepine withdrawal symptoms in primates. Eur. J. Pharmacol. 132:1986;31-38.
14. Gallager D.W., Malcolm A.B., Anderson S.A., Gonsalves S.F. Continuous release of diazepam. Electrophysiological, biochemical and behavioral consequences Brain Res. 342:1985;26-36.
15. 35S]t-butylbicyclophosphorothionate binding to a chloride ionosphore in rat brain via a novel Ro 5 4864 binding site. J. Phamacol. Exp. Ther. 240:1987;747-753.
16. Gee K.W., Bolger M.B., Brinton R.E., Coirini H., McEwen B.S. Steroid modulation of the chloride ionophore in rat brain. Structure-activity requirements, regional dependence and mechanism of action J. Pharmacol. Exp. Ther. 246:1988;803-812.
17. Gerak L.R., France C.P. Effects of repeated exposure to flumazenil on schedule-controlled behaviour in chlordiazepoxide-treated rhesus monkeys. Soc. Neurosci. Abstr. 22:1996;2075.
18. Greenblatt D.J., Divoll M.K., Harmatz J.S., Shader R.I. Oxazepam kinetics. Effects of age and sex J. Pharmacol. Exp. Ther. 215:1980;86-91.
19. Greenblatt D.J., Divoll M.K., Abernethy D.R., Ochs H.R., Harmatz J.S., Shader R.I. Age and gender effects on chlordiazepoxide kinetics. Relation to antipyrine disposition Pharmacology. 38:1989;327-334.
20. A subunit mRNA in rat brain. J. Mol. Neurosci. 2:1990;101-107.
21. Hertz L. Binding characteristics of the receptor and coupling to transport proteins. Giesen-Crouse E. Peripheral benzodiazepine receptors. 1993;27-59 Academic Press, London.
22. Honack D., Losher W. Sex differences in NMDA receptor mediated responses in rats. Brain Res. 620:1993;167-170.
23. Hunkler W., Mohler H., Pieri L., Polc P., Bonetti E.P., Cumin R., Schaffner R., Haefely W. Selective antagonists of benzodiazepine. Nature. 290:1981;514-516.
24. Itzhak Y., Baker L., Norenberg M.D. Characterization of the peripheral-type benzodiazepine receptors in cultured astrocytes. Evidence for multiplicity Glia. 9:1993;211-218.
25. Iwaya N., Morita Y., Miyoshi K. Determination of pharmacodynamics of diazepam by quantitative pharmaco-EEG. Jpn. J. Psychiatr. Neurol. 43:1989;675-684.
26. Krueger, K. E.; Papadopoulos, A.: The role of mitochondrial benzodiazepine receptors in steroidogenesis. In: Giesen-Crouse, E., ed. Peripheral benzodiazepine receptors. London: Academic Press Ltd. 1993: 89-124.
27. Lamb R.J., Griffiths R.R. Effects of repeated Ro 151788 administration in benmzodiazepine-dependent baboons. Eur. J. Pharmacol. 119:1985;2578-2610.
28. Lamb R.J., Griffiths R.R. Effects of Ro 151788 and CGS 8216 in diazepam-dependent baboons. Eur. J. Pharmacol. 143:1987;205-212.
29. Le Fur G., Guilloux F., Rufat P., Benavides J., Uzan A., Renault C., Dubroeucq M.-C., Geueremy C. Peripheral benzodiazepine binding sites. Effect of PK 11195, 1-(2-chlorophenyl)-N-methyl)1-methylpropyl)-3-isoquinolinecarboxamide. II. In vivo studies Life Sci. 31:1983;1849-1856.
30. Liser R.G., Greenblatt D.J., Abernathy D.R., File S.E. Pharmacokinetic studies on Ro 15-1788, a benzodiazepine receptor ligand, in the brain of the rat. Brain Res. 290:1984;183-186.
31. Loscher W., Ebert U., Lehmann H., Rosenthal C., Nikkhah G. Seizure suppression in kindling epilepsy by grafts of fetal GABAergic neurons in rat substantia nigra. Soc. Neurosci. Abstr. 22:1996;1655.
32. A receptor function by neuroactive steroids. Brain Res. 819:1992;75-82.
33. A receptor isoforms Can. J. Physiol. Pharmacol. 76:1998;909-920.
34. Mandema J.W., Gubbens-Stibbe J.M., Danhof M. Stability and pharmacokinetics of flumazenil in the rat. Psychopharmacology (Berlin). 103:1991;384-387.
35. Mandema J.W., Tukker E., Danhof M. In vivo characterization of the pharmacodynamic interaction of a benzodiazepine agonist and antagonist. Midazolam and flumazenil J. Pharmacol. Exp. Ther. 260:1992;36-44.
36. Martin J.R., Moreau J.L., Jeneck F. Precipitated withdrawal in squirrel monkeys after repeated daily oral administration of alprozolam, diazepam, flunitrazepam or oxazepam. Psychopharmacology (Berlin). 118:1995;273-279.
37. Martin W.R., Sloan J.W., Wala E.P. Precipitated abstinence in the diazepam-dependent rat. Pharmacol. Biochem. Behav. 46:1993;683-688.
38. Martinez J.A., Fargeas M.J., Bueno L. Physical dependence on diazepam. Precipitation of abstinence syndromes by peripheral and central benzodiazepine receptor antagonists Pharmacol. Biochem. Behav. 41:1992;461-464.
39. 3) in the tolerance to the electroencephalographic effects of benzodiazepines in rats. Comparison of diazepam and clonazepam Pharmacol. Biochem. Behav. 35:1990;933-936.
40. McCabe R.T., Wamsley J.K. Autoradiographic localization fo subcomponents of the macromolecular GABA receptor complex. Life Sci. 39:1986;1937-1945.
41. Mele L., Sagratella S., Massotti M. Chronic administration of diazepam to rats causes changes in EEG patterns and in coupling between GABA receptors and benzodiazepine binding sites in vitro. Brain Res. 323:1984;93-102.
42. Miller L.G., Galpern W.R., Byrnes J.J., Greenblatt D.J., Shader R.I. Chronic benzodiazepine administration. X. Concurrent administration of the peripheral-type benzodiazepine ligand PK 11195 attentuates chronic efects of lorazepam. J. Pharmacol. Exp. Ther. 261:1992;285-289.
43. Mohler H., Burkard W.P., Keller H.H., Richards J.G., Haefely G. Benzodiazepine antagonist Ro 15-1788. Binding characteristics and interaction with drug-induced changes in dopamine turnover and cerebellar cGMP levels J. Neurochem. 37:1981;714-722.
44. Moran M.H., Goldber M., Smith S.S. Progesterone withdrawal II. Insensitivity to the sedative effects of a benzodiazepine Brain Res. 807:1998;91-100.
45. Moran M.H., Smith S.S. Progesterone withdrawal I. Pro-convulsant effects Brain Res. 807:1998;84-90.
46. 3H] Flunitrazepam binding sites J. Neurochem. 49:1987;890-899.
47. A receptors. FASEB J. 4:1990;1469-1480.
48. Ovtscharoff W., Eusterschulte B., Zienecker R., Reisert I., Pilgrim C. Sex differences in densities of dopaminergic fibers and GABAergic neurons int he prenatal rat striatum. J. Comp. Neurol. 333:1992;299-304.
49. Paxinos G., Watson C. The rat brain in sterotaxic coordinates. 2nd ed:1986;Academic Press, Sydney.
50. Pazos A., Cymerman U., Probst A., Palacios J.M. Peripheral benzodiazepine binding sites in human brain and kidney. Autoradiographic studies Neurosci. Lett. 66:1986;147-152.
51. Pericic D., Bujas M. Sex differences in bicuculline-induced convulsions. Interaction with stress and ligands of benzodiazepine binding sites Brain Res. 752:1997;279-284.
52. Pericic D., Pivac N. Effects of diazepam on conflict behaviour and on plasma corticosterone levels in male and female rats. Naunyn Schmiedebergs Arch. Pharmacol. 353:1996;369-376.
53. A receptor subunits in the rat CNS. J. Comp. Neurol. 326:1992;193-216.
54. Pesce M.E., Acevedo X., Pinardi G., Miranda H.F. Gender differences in diazepam withdrawal syndrome in mice. Pharmacol. Toxicol. 75:1994;353-355.
55. Ramsey V.A., Tietz E.I., Rosenberg H.C. Chronic flurazepam differentially regulates a behavioral effect of GABA agonists. Pharmacol. Biochem Behav. 38:1991;659-663.
56. Reilly P.E., Thompson D.A., Mason S.R., Hooper W.D. Cytochrome P450IIIA enzymes in rat liver microsomes. Involvement in C3-hydroxylation of diazepam and nordiazepam but not N-dealkylation of diazepam and temazepam Mol Pharmacol. 37:1990;767-774.
57. Robinson T.E., Camp D.M., Jacknow D.S., Becker J.B. Sex differences and estrous cycle dependent variation in rotational behavior elicited by electrical stimulation of the mesostriatal dopamine system. Behav. Brain Res. 6:1982;273-287.
58. Rosenberg H.C., Tietz E.I., Zhang H., Chiu T. Tolerance to diazepam and methyl-β-carboline-3-caboxylate measured in substantia nigra of benzodiazepine tolerant rats. Life Sci. 46:1990;519-525.
59. Ross R.J., Waszczak B.L., Lee E.K., Walters J.R. Effects of benzodiazepines on single unit activity in the substantia nigra pars reticulata. Life Sci. 31:1982;1025-1035.
60. Saano V., Rago L., Raty M. Peripheral benzodiazepine binding sites. Pharmacol. Ther. 41:1989;503-514.
61. Sloan J.W., Martin W.R., Wala E.P. The effect of the chronic dose of diazepam on the intensity and characteristics of the precipitated abstinence syndrome in the dog. J. Pharmacol. Exp. Therp. 265:1993;11152-11162.
62. Sloan J.W., Martin W.R., Wala E.P., Dickey K.M. chronic administration of and dependence on halzepam, dizepam, and nordiazepam in the dog. Drug Alcohol Depend. 28:1991;249-264.
63. Sloan J.W., Wala E.P., Jing X. PK 11195-evoked withdrawal in diazepam-dependent rats; Effect of dose of PK, DZ and gender. Soc. Neurosci. Abstr. 23:1997;2392.
64. Sloan J.W., Wala E.P., Jing X. Effect of repeated (daily vs. weekly) administration of PK 11195 on precipitated withdrawal scores in diazepam-dependent male and female rats. Soc. Neurosci. Abstr. 24:1998;196.
65. Sloan J.W., Wala E.P., Jing X., Holtman P.H. Effect of gender on physical dependence on diazepam in rats. Soc. Neurosci. Abstr. 22:1996;2075.
66. Sloan J.W., Wala E.P., Jing X., Holtman J.R. Jr., Milliken B. Diazepam-treated female rat. Flumazenil- and PK 11195-induced withdrawal in the hippocampus CA1 Pharmacol. Biochem. Behav. 60:1998;1-10.
67. Stefanova N., Bozhilova-Pastirova A., Ovtscharoff W. Sex and age differences of neurons expressing GABA-immunoreactivity in the rat bed nucleus of the stria terminals. Int. J. Dev. Neurosci. 16:1998;443-448.
68. Stock H.S., Ford K., Biscardi R., Wilson M.A. Are there sex differences in anxiety levels following precipitated benzodiazepine withdrawal in rats. Soc. Neurosci Abstr. 23:1997;2392.
69. Strobel B.A. Anatomical distribution of NADPH-cytochrome P450 reductase and cytochrome P4502D forms in rat brain. Effects of xenobiotics and sex steroids Mol. Cell. Biochem. 162:1996;31-41.
70. Tietz E.I., Rosenberg H.C. Behavioral measurement of benzodiazepine tolerance and GABAergic subsensitivity in the substantia nigra pars reticulata. Brain Res. 438:1988;41-51.
71. Tietz E.I., Rosenberg H.C., Chiu T.H. Autoradiographic localization of benzodiazepine receptor downregulation. J. Pharmacol. Exp. Ther. 236:1986;284-292.
72. Tyma J.L., Rosenberg H.C., Tietz E.I., Chiu T.H. Effects of chronic flurazepam treatment on firing rate of rat substantia nigra pars reticulata neurons. Brain Res. 453:1988;344-348.
73. Valerio A., Massotti M. Electroencephalographic changes after short-term exposure to agonists of benzodiazepine receptors in the rat. Pharmacol. Biochem. Behav. 29:1988;791-795.
74. Van Haaren F., Katon E., Anderson K.G. The effects of chlordiazepoxide on low-rate behavior are gender dependent. Pharmacol. Biochem. Behav. 58:1997;1037-1043.
75. Wala E.P., Sloan J.W., Jing X. Comparison of abstinence syndromes precipitated by flumazenil and PK 11195 in female diazepam-dependent rats. Psychopharmacology (Berlin). 133:1997;214-223.
76. Wala E.P., Sloan J.W., Jing X. Dorsal raphe and substantia nigra response to flumazenil in diazepam-dependent rats. Pharmacol. Biochem. Behav. 58:1997;221-229.
77. Wala E.P., Sloan J.W., Jing X. Pharmacokinetics of PK 11195 an antagonist of the peripheral benzodiazepine receptors, in rats. Soc. Neurosci Abstr. 24:1998;196.
78. Wala, E. P.; Sloan, J. W.; Jing, X.: Substantia nigra: The involvement of central and peripheral benzodiazepine receptors in physical dependence on diazepamas evidenced by behavioral and EEG effects. Phamacol. Biochem. Behav. (in press).
79. Wala E.P., Sloan J.W., Jing X., Holtman P.H. Intrathecally administered flumazenil and PK 11195 precipitate abstinence syndrome in freely moving diazepam dependent rats. Drug Alcohol Depend. 43:1996;169-177.
80. Wang H., Strobel B.A. Regulation of CYP3A9 gene expression by estrogen and catalytic studies using cytochrome P4503A9 expressed in Escherichia coli. Arch. Biochem. Biophys. 344:1997;365-372.
81. Waszczak B.L., Lee E.F., Walters J.R. Effects of anticonvulsant drugs on substantia nigra pars reticulata neurons. J. Pharmacol. Exp. Ther. 239:1986;661-671.
82. Watanabe M., Tanoka M., Tateishi T., Nakura H., Kumai T., Kobayashi S. Effects of the estrous cycle and the gender difference on hepatic drug-metabolizing enzyme activities. Pharmacol. Res. 35:1997;477-480.
83. A receptor and central-type and peripheral-type benzodiazepine receptors. Brain Res. 752:1997;307-314.
84. Weizman R., Leschiner S., Schlegel W., Gavish M. Peripheral-type benzodiazepine receptor ligands and serum steroid hormones. Brain Res. 772:1997;203-208.
85. Wilson M.A. Influences of gender, gonadectomy, and estrous cycle on GABA/BZ receptors and benzodiazepine responses in rats. Brain Res. Bull. 29:1992;167-172.
86. Wilson M.A. Influences of the hormonal milieu on acute and chronic benzodiazepine responses in rats. Watson R. Drugs of abuse and neurobiology. 1992;209-231 CRC Press, Ann Arbor.
87. Wilson M.A. Divergent alterations in γ-aminobutyric acid/benzodiazepine responses of male and ovariectomized rats after chronic benzodiazepine agonist exposure. Electrophysiological analysis of substantia nigra pars reticulata neurons J. Pharmacol. Exp. Ther. 266:1993;774-779.
88. Wilson M.A. Gonadextomy and sex modulate spontaneous activity of substantia nigra pars reticulata neurons without modifying GABA/benzodiazepine responsiveness. Life Sci. 53:1993;217-225.
89. Wilson M.A., Biscardi R. Effects of gender and gonadectomy on responses to chronic benzodiazepine receptor agonist exposure in rats. Eur.J. Pharmacol. 215:1992;99-107.
90. Wilson M.A., Biscardi R. Influence of gender and brain region on neurosteroid modulation of GABA responses in rats. Life Sci. 80:1997;1679-1691.
91. Wilson M.A., Frye C.A. Effects of chronic benzodiazepine exposure on stress-induced neuroactive steroid levels. Brain Res. 824:1999;136-139.
92. Wilson M.A., Gallager D.W. Effects of chronic diazepam exposure on GABA sensitivity and on benzodiazepine potentiation of GABA-mediated responses of substantia nigra pars reticulata neurons of rats. Eur. J. Pharmacol. 136:1987;333-343.
93. Wilson M.A., Gallager D.W. Ro 15-1788-induced seizures in rats continually exposed to diazepam for prolonged periods. Epilepsy Res. 2:1988;14-19.
94. Wilson M.A., Gallager D.W. Responses of substantia nigra pars reticulata neurons to benzodiazepine ligands after acute and prolonged diazepam exposure. I. Modulation of γ-aminobutyric acid sensitivity. J. Pharmacol. Exp. Ther. 248:1989;879-885.
95. Wilson M.A., Gallager D.W. Responses of substantia nigra pars reticulata neurons to benzodiazepine ligands after acute and prolonged diazepam exposure. II. Modulation of firing rate. J. Pharmacol. Exp. Ther. 248:1989;886-891.
96. Woods J.H., Katz J.L., Winger G. Benzodiazepines. Use, abuse and consequences Pharmacol. Rev. 44:1992;169-189.
97. Young W.S., Niehoff D., Kuhar M.J., Beer B., Lippa A.S. Multiple benzodiazepine receptor localization by light microscopic radiohistochemistry. J. Pharmacol. Exp. Ther. 216:1981;425-430.
98. Yuan J., Goehl T.J., Hong L., Clark J., Murril E., Moore R. Toxicokinetics of oxazepam in rats and mice. J Pharm. Sci. 83:1994;1373-1375.
99. Zezula J., Cortes R., Probist A., Palacios J.M. Benzodiazepine receptor sites in the human brain. Audiographic mapping Neuroscience. 25:1988;771-795.
100. Zhang H., Rosenberg H.C., Tietz E.I. Injection of benzodiazepines but not GABA or muscimol into pars reticulata of substantia nigra suppresses pentylenetetrazol seizures. Brain Res. 488:1989;73-79.